Clinical trial of hadacidin (NSC-521778) at three fractionated dose levels.
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male
D000903:Antibiotics, Antineoplastic